Details for New Drug Application (NDA): 020969
✉ Email this page to a colleague
The generic ingredient in UVADEX is methoxsalen. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
Summary for 020969
Tradename: | UVADEX |
Applicant: | Mallinckrodt Hosp |
Ingredient: | methoxsalen |
Patents: | 0 |
Pharmacology for NDA: 020969
Mechanism of Action | Photoabsorption |
Physiological Effect | Photosensitizing Activity |
Medical Subject Heading (MeSH) Categories for 020969
Suppliers and Packaging for NDA: 020969
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
UVADEX | methoxsalen | INJECTABLE;INJECTION | 020969 | NDA | Therakos, Inc. | 64067-216 | 64067-216-01 | 12 VIAL, GLASS in 1 CARTON (64067-216-01) / 10 mL in 1 VIAL, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.02MG/ML | ||||
Approval Date: | Feb 25, 1999 | TE: | RLD: | Yes |
Expired US Patents for NDA 020969
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mallinckrodt Hosp | UVADEX | methoxsalen | INJECTABLE;INJECTION | 020969-001 | Feb 25, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Mallinckrodt Hosp | UVADEX | methoxsalen | INJECTABLE;INJECTION | 020969-001 | Feb 25, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Mallinckrodt Hosp | UVADEX | methoxsalen | INJECTABLE;INJECTION | 020969-001 | Feb 25, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription